Cost Of Drug Treatment In Medicare's Top Therapeutic Areas Dropping Quickly With Generics, IMS Data Show
This article was originally published in The Pink Sheet Daily
Executive Summary
IMS exec says average cost per day of drug treatment in top 10 Part D drug classes will drop to about 50¢ a day by 2014.
You may also be interested in...
Global Pharmaceutical Sales Expected To Reach $880 billion in 2011
IMS Health says the pharmaceutical industry will do better in 2011 than it is doing this year, but a full rebound is not on the horizon, as generics and payor restrictions continue to take a toll.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.